Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
Clinical trial NCT06679881 · RECRUITING
Trial details
- NCT number
- NCT06679881
- Sponsor
- Pharvaris Netherlands B.V.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2028-12-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.